Persistent Atrial Fibrillation
Pipeline by Development Stage
Drug Modality Breakdown
On Market (2)
Approved therapies currently available
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 39 trials with date data
Clinical Trials (40)
Total enrollment: 40,231 patients across 40 trials
Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
Irbesartan and Adhesion Molecules in AF
ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination
Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients
Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria
I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients
Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome
Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
AMISH : Aprovel for Management of Isolated Systolic Hypertension
Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population
Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol
The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension
Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice
Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension
Irbesartan in Type 2 Diabetes
Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy
Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation
Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers
Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)
Irbesartan and Atenolol in Hypertensive Heart Disease
Irbesartan and Amlodipine Combination in Controlling Blood Pressure
Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation
FIRE AND ICE II Trial Pilot
AF Substrate Mapping and Guided Ablation